When to adjust therapy in patients with rheumatoid arthritis after initiation of etanercept plus methotrexate or methotrexate alone: findings from a randomized study …
…, Y Brault, AS Koenig, IS Logeart - The Journal of …, 2014 - jrheum.org
Objective. The objective of these posthoc analyses was to evaluate short-term clinical
outcomes as predictors of poor response after 1 year of treatment with combination etanercept/…
outcomes as predictors of poor response after 1 year of treatment with combination etanercept/…
Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement
…, P Ravaud, G Baron, B Falissard, I Logeart… - Annals of the …, 2005 - ard.bmj.com
Background: In clinical trials, at the group level, results are usually reported as mean and
standard deviation of the change in score, which is not meaningful for most readers. Objective: …
standard deviation of the change in score, which is not meaningful for most readers. Objective: …
Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state
…, P Ravaud, G Baron, B Falissard, I Logeart… - Annals of the …, 2005 - ard.bmj.com
Background: The patient acceptable symptom state (PASS) is the value beyond which patients
can consider themselves well. This concept can help in interpreting results of clinical trials…
can consider themselves well. This concept can help in interpreting results of clinical trials…
[PDF][PDF] Symptomatic efficacy of etanercept and its effects on objective signs of inflammation in early nonradiographic axial spondyloarthritis: a multicenter, randomized …
…, R Bonin, MU Rahman, I Logeart… - Arthritis & …, 2014 - Wiley Online Library
Objective To assess the efficacy of etanercept in the treatment of early active nonsteroidal
antiinflammatory drug (NSAID)–refractory nonradiographic axial spondyloarthritis (SpA). …
antiinflammatory drug (NSAID)–refractory nonradiographic axial spondyloarthritis (SpA). …
Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain …
…, M Hochberg, I Logeart… - Arthritis care & …, 2012 - Wiley Online Library
Objective To estimate the minimum clinically important improvement (MCII) and patient
acceptable symptom state (PASS) values for 4 generic outcomes in 5 rheumatic diseases and 7 …
acceptable symptom state (PASS) values for 4 generic outcomes in 5 rheumatic diseases and 7 …
The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients
…, B Fautrel, A Feydy, P Goupille, V Leblanc, I Logeart… - Joint bone spine, 2011 - Elsevier
OBJECTIVES: The French Society of Rheumatology has initiated a large national multicenter,
longitudinal, prospective follow-up of patients presenting with early inflammatory back pain …
longitudinal, prospective follow-up of patients presenting with early inflammatory back pain …
The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients
…, RM Flipo, P Goupille, F Guillemin, X Le Loet, I Logeart… - Joint bone spine, 2007 - Elsevier
OBJECTIVES: The French Society of Rheumatology initiated a large national multicenter,
longitudinal and prospective cohort, the so-called “ESPOIR cohort study” in order to set up …
longitudinal and prospective cohort, the so-called “ESPOIR cohort study” in order to set up …
Feeling good rather than feeling better matters more to patients
…, B Falissard, G Baron, I Logeart… - Arthritis Care & …, 2006 - Wiley Online Library
Objective To determine the most appropriate means to assess the response to treatment in
terms of pain and functional impairment in a chronic rheumatic condition (knee osteoarthritis […
terms of pain and functional impairment in a chronic rheumatic condition (knee osteoarthritis […
Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after …
…, I Logeart, MC Belkacemi, S Dadoun… - Annals of the …, 2015 - ard.bmj.com
Objective To investigate if patients with early RA with persistent moderate disease activity
during the first year after diagnosis have a worse 3–5 year outcome than those who achieve …
during the first year after diagnosis have a worse 3–5 year outcome than those who achieve …
Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis: 48-week results from the EMBARK study
…, G Citera, F Van den Bosch, I Logeart… - Annals of the …, 2016 - ard.bmj.com
… Isabelle Logeart8, … If you wish to reuse any or all of this article please use the link below
which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to …
which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to …